FDA Investigators Share Insights on First-Line Immunotherapy Regimens in NSCLC

Press/Media

Period	Jun 4 2022

Media coverage

Title	FDA Investigators Share Insights on First-Line Immunotherapy Regimens in NSCLC
Media name/outlet	GenomeWeb
Country/Territory	United States
Date	06/4/22
URL	https://www.genomeweb.com/molecular-diagnostics/fda-investigators-share-insights-first-line-immunotherapy-regimens-nsclc
Persons	Sukhmani Kaur Padda